MYKHALOIKO, I.; YATSYSHYN, R. Apixaban versus warfarin in nephrotic syndrome: thromboembolic events, bleeding risk and changes in profibrotic and inflammatory cytokines. Ukrainian Journal of Nephrology and Dialysis, n. 2(90), p. 20-31, 11 Jun. 2026.